The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Life Science Market Reports

SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. In 2017, the global Acromegaly Therapeutics market size was xx million US$ and is forecast to xx.....

No Of Pages : 112
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisAcromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. In 2017, the global Acromegaly Drugs market size was xx million US$ and is forecast to xx millio.....

No Of Pages : 111
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. In 2017, the global Hemin market size was xx million US$ and is forecast to xx million US in 2025, growing a.....

No Of Pages : 112
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. In 2017, the global Panhematin market size was xx million US$ and is forecast to xx million US in 2025,.....

No Of Pages : 116
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisHemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. In 2017, the global Hemin Drugs market size was xx million US$ and is forecast to xx million US in 2025, gro.....

No Of Pages : 115
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. In 2017, the global Panhematin Drugs market size was xx million US$ and is forecast to xx million US in.....

No Of Pages : 113
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisSwedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. In 2017, the global Swedish Porphyria market s.....

No Of Pages : 119
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....

No Of Pages : 111
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....

No Of Pages : 111
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....

No Of Pages : 110
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisSwedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. In 2017, the global Swedish Porphyria Drugs ma.....

No Of Pages : 116
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisSwedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. In 2017, the global Swedish Porphyria Treatmen.....

No Of Pages : 110
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisSwedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. In 2017, the global Swedish Porphyria Therapeu.....

No Of Pages : 115
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisNelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. In 2017, the global Nelarabine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to.....

No Of Pages : 111
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00

SynopsisArranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. In 2017, the global Arranon market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to defin.....

No Of Pages : 113
Publication Date: Nov, 2018
Single User Price : US$ 3,900.00